CMS operates the quality improvement organization (QIO) program to improve the quality of care delivered to Medicare beneficiaries. Although there have been several studies regarding the effectiveness of this program, there have not been studies regarding this program's value. This article seeks to answer the value question using costutility analysis. Although additional research is warranted, ...

To solve the problem that process capability optimization in multistage manufacturing processes has not been studied so much. Firstly, a multistage manufacturing process quality variation model is built to analyze the impaction of each stage quality on process capability. Then, a multistage manufacturing process capability analysis method with “Costutility ratio” is proposed to prioritize proce...

Screening for early detection is a primary way to control breast cancer. The choice of e ective screening policies involves substantial uncertainty and di cult tradeo s among medical costs and the duration and quality of life. In this paper, we study the choice of the age at which screening should begin and the frequency of screening tests. These have been issues of important debate in the heal...

4. Özsoylu S, Allahverdi H, Laleli Y, Pirnar A. Platelet survival in childhood idiopathic thrombocytopenic purpura in remission. J Pediatr 1976;89:388-390. 5. Özsoylu Ş, Karabent A, Irken G, Tuncer M. Antiplatelet antibody in childhood idiopathic thrombocytopenic purpura. Am J Hematol 1991;36:82-85. 6. Özsoylu Ş, Ertürk G. Oral megadose methylprednisolone for acute childhood idiopathic thromboc...

Screening for early detection is a primary way to control breast cancer. The choice of e ective screening policies involves substantial uncertainty and di cult tradeo s among medical costs and the duration and quality of life. In this paper, we study the choice of the age at which screening should begin and the frequency of screening tests. These have been issues of important debate in the heal...

www.chestpubs.org with once daily tiotropium compared with twice daily salmeterol in patients with COPD . Thorax . 2003 ; 58 ( 5 ): 399 404 . 12 . Brusasco V , Hodder R , Miravitlles M , Korducki L , Towse L , Kesten S . Health outcomes following treatment for 6 months with once daily tiotropium compared with twice daily salmeterol in patients with COPD . Thorax . 2006 ; 61 ( 1 ): 91 . 13 . Cal...